nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—NR3C1—hypertension	0.349	1	CbGaD
Flurandrenolide—Drospirenone—Eplerenone—hypertension	0.0706	0.151	CrCrCtD
Flurandrenolide—NR3C1—Spironolactone—hypertension	0.0687	1	CbGbCtD
Flurandrenolide—Drospirenone—Spironolactone—hypertension	0.0614	0.131	CrCrCtD
Flurandrenolide—Medroxyprogesterone Acetate—Eplerenone—hypertension	0.0547	0.117	CrCrCtD
Flurandrenolide—Hydrocortamate—Eplerenone—hypertension	0.0494	0.106	CrCrCtD
Flurandrenolide—Medroxyprogesterone Acetate—Spironolactone—hypertension	0.0476	0.102	CrCrCtD
Flurandrenolide—Hydrocortamate—Spironolactone—hypertension	0.043	0.0919	CrCrCtD
Flurandrenolide—Fludrocortisone—Eplerenone—hypertension	0.0416	0.0889	CrCrCtD
Flurandrenolide—Fludrocortisone—Spironolactone—hypertension	0.0362	0.0773	CrCrCtD
Flurandrenolide—Hydrocortisone—Eplerenone—hypertension	0.0339	0.0725	CrCrCtD
Flurandrenolide—Hydrocortisone—Spironolactone—hypertension	0.0295	0.0631	CrCrCtD
Flurandrenolide—Hypertrichosis—Spironolactone—hypertension	0.00318	0.0439	CcSEcCtD
Flurandrenolide—Hypertrichosis—Betaxolol—hypertension	0.00171	0.0237	CcSEcCtD
Flurandrenolide—NR3C1—urine—hypertension	0.00162	0.128	CbGeAlD
Flurandrenolide—Skin discolouration—Esmolol—hypertension	0.00131	0.0181	CcSEcCtD
Flurandrenolide—Skin discolouration—Amlodipine—hypertension	0.00117	0.0162	CcSEcCtD
Flurandrenolide—Skin discolouration—Nisoldipine—hypertension	0.00117	0.0162	CcSEcCtD
Flurandrenolide—Skin discolouration—Guanabenz—hypertension	0.0011	0.0153	CcSEcCtD
Flurandrenolide—Eruption—Furosemide—hypertension	0.00107	0.0148	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—hypertension	0.00101	0.0431	CbGpPWpGaD
Flurandrenolide—SERPINA6—nephron tubule—hypertension	0.000994	0.0785	CbGeAlD
Flurandrenolide—Dermatitis contact—Diltiazem—hypertension	0.000875	0.0121	CcSEcCtD
Flurandrenolide—SERPINA6—kidney—hypertension	0.000873	0.069	CbGeAlD
Flurandrenolide—SERPINA6—cortex of kidney—hypertension	0.00085	0.0672	CbGeAlD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—SRF—hypertension	0.000805	0.0343	CbGpPWpGaD
Flurandrenolide—Dermatitis contact—Clonidine—hypertension	0.000738	0.0102	CcSEcCtD
Flurandrenolide—SERPINA6—adrenal gland—hypertension	0.000706	0.0558	CbGeAlD
Flurandrenolide—NR3C1—cardiac ventricle—hypertension	0.000631	0.0499	CbGeAlD
Flurandrenolide—SERPINA6—endocrine gland—hypertension	0.000612	0.0484	CbGeAlD
Flurandrenolide—NR3C1—myocardium—hypertension	0.000594	0.0469	CbGeAlD
Flurandrenolide—Hypersensitivity—Triamterene—hypertension	0.000553	0.00764	CcSEcCtD
Flurandrenolide—SERPINA6—central nervous system—hypertension	0.000552	0.0436	CbGeAlD
Flurandrenolide—NR3C1—Signaling events mediated by HDAC Class II—HDAC5—hypertension	0.000523	0.0222	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—RCHY1—hypertension	0.000501	0.0213	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Hydroflumethiazide—hypertension	0.000479	0.00663	CcSEcCtD
Flurandrenolide—NR3C1—brainstem—hypertension	0.000479	0.0379	CbGeAlD
Flurandrenolide—Infection—Methyldopa—hypertension	0.000476	0.00658	CcSEcCtD
Flurandrenolide—Rash—Triamterene—hypertension	0.000473	0.00654	CcSEcCtD
Flurandrenolide—Dermatitis—Triamterene—hypertension	0.000472	0.00654	CcSEcCtD
Flurandrenolide—Amcinonide—ANXA1—hypertension	0.000468	0.078	CrCbGaD
Flurandrenolide—NR3C1—Signaling events mediated by HDAC Class II—SRF—hypertension	0.000462	0.0197	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—GATA6—hypertension	0.00046	0.0196	CbGpPWpGaD
Flurandrenolide—Infection—Quinapril—hypertension	0.000453	0.00627	CcSEcCtD
Flurandrenolide—Pruritus—Reserpine—hypertension	0.000447	0.00618	CcSEcCtD
Flurandrenolide—Infection—Benazepril—hypertension	0.000446	0.00617	CcSEcCtD
Flurandrenolide—Hypersensitivity—Nebivolol—hypertension	0.000438	0.00606	CcSEcCtD
Flurandrenolide—Rash—Bendroflumethiazide—hypertension	0.000438	0.00605	CcSEcCtD
Flurandrenolide—Dermatitis—Bendroflumethiazide—hypertension	0.000437	0.00605	CcSEcCtD
Flurandrenolide—NR3C1—nephron tubule—hypertension	0.000435	0.0344	CbGeAlD
Flurandrenolide—Infection—Nicardipine—hypertension	0.000434	0.00601	CcSEcCtD
Flurandrenolide—NR3C1—adrenal cortex—hypertension	0.000428	0.0339	CbGeAlD
Flurandrenolide—Pruritus—Nebivolol—hypertension	0.000421	0.00582	CcSEcCtD
Flurandrenolide—NR3C1—heart—hypertension	0.000414	0.0327	CbGeAlD
Flurandrenolide—NR3C1—smooth muscle tissue—hypertension	0.000411	0.0325	CbGeAlD
Flurandrenolide—Rash—Hydroflumethiazide—hypertension	0.00041	0.00567	CcSEcCtD
Flurandrenolide—Dermatitis—Hydroflumethiazide—hypertension	0.00041	0.00567	CcSEcCtD
Flurandrenolide—NR3C1—decidua—hypertension	0.000403	0.0318	CbGeAlD
Flurandrenolide—Hypersensitivity—Chlorothiazide—hypertension	0.000402	0.00556	CcSEcCtD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—NR3C2—hypertension	0.000402	0.0171	CbGpPWpGaD
Flurandrenolide—Rash—Reserpine—hypertension	0.000398	0.00551	CcSEcCtD
Flurandrenolide—Rash—Ethacrynic acid—hypertension	0.000398	0.00551	CcSEcCtD
Flurandrenolide—Dermatitis—Ethacrynic acid—hypertension	0.000398	0.00551	CcSEcCtD
Flurandrenolide—Dermatitis—Reserpine—hypertension	0.000398	0.00551	CcSEcCtD
Flurandrenolide—Hypersensitivity—Chlorthalidone—hypertension	0.000395	0.00546	CcSEcCtD
Flurandrenolide—Hypersensitivity—Prazosin—hypertension	0.000392	0.00543	CcSEcCtD
Flurandrenolide—NR3C1—cardiovascular system—hypertension	0.000391	0.0309	CbGeAlD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—hypertension	0.000389	0.0166	CbGpPWpGaD
Flurandrenolide—Medroxyprogesterone Acetate—HSD3B2—hypertension	0.000385	0.0642	CrCbGaD
Flurandrenolide—NR3C1—kidney—hypertension	0.000382	0.0302	CbGeAlD
Flurandrenolide—Pruritus—Prazosin—hypertension	0.000377	0.00521	CcSEcCtD
Flurandrenolide—Pruritus—Bumetanide—hypertension	0.000377	0.00521	CcSEcCtD
Flurandrenolide—Rash—Nebivolol—hypertension	0.000375	0.00519	CcSEcCtD
Flurandrenolide—Dermatitis—Nebivolol—hypertension	0.000375	0.00518	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—hypertension	0.000375	0.0159	CbGpPWpGaD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—hypertension	0.000373	0.0159	CbGpPWpGaD
Flurandrenolide—NR3C1—cortex of kidney—hypertension	0.000372	0.0294	CbGeAlD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—hypertension	0.000363	0.0154	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALAS1—hypertension	0.000363	0.0154	CbGpPWpGaD
Flurandrenolide—NR3C1—cardiac atrium—hypertension	0.000354	0.028	CbGeAlD
Flurandrenolide—Rash—Torasemide—hypertension	0.000353	0.00489	CcSEcCtD
Flurandrenolide—Infection—Guanabenz—hypertension	0.000353	0.00489	CcSEcCtD
Flurandrenolide—Dermatitis—Torasemide—hypertension	0.000353	0.00488	CcSEcCtD
Flurandrenolide—Hypersensitivity—Methyldopa—hypertension	0.000353	0.00488	CcSEcCtD
Flurandrenolide—Hypersensitivity—Hydralazine—hypertension	0.000346	0.00479	CcSEcCtD
Flurandrenolide—Rash—Chlorothiazide—hypertension	0.000344	0.00476	CcSEcCtD
Flurandrenolide—Dermatitis—Chlorothiazide—hypertension	0.000344	0.00476	CcSEcCtD
Flurandrenolide—Pruritus—Candesartan—hypertension	0.000344	0.00475	CcSEcCtD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—hypertension	0.000343	0.0146	CbGpPWpGaD
Flurandrenolide—Rash—Chlorthalidone—hypertension	0.000338	0.00467	CcSEcCtD
Flurandrenolide—Dermatitis—Chlorthalidone—hypertension	0.000337	0.00467	CcSEcCtD
Flurandrenolide—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—hypertension	0.000337	0.0143	CbGpPWpGaD
Flurandrenolide—Rash—Prazosin—hypertension	0.000336	0.00464	CcSEcCtD
Flurandrenolide—Rash—Bumetanide—hypertension	0.000336	0.00464	CcSEcCtD
Flurandrenolide—Dermatitis—Prazosin—hypertension	0.000335	0.00464	CcSEcCtD
Flurandrenolide—Dermatitis—Bumetanide—hypertension	0.000335	0.00464	CcSEcCtD
Flurandrenolide—NR3C1—medulla oblongata—hypertension	0.000334	0.0264	CbGeAlD
Flurandrenolide—Pruritus—Amiloride—hypertension	0.000333	0.0046	CcSEcCtD
Flurandrenolide—Pruritus—Hydralazine—hypertension	0.000333	0.0046	CcSEcCtD
Flurandrenolide—Hypersensitivity—Benazepril—hypertension	0.000331	0.00458	CcSEcCtD
Flurandrenolide—Pruritus—Pindolol—hypertension	0.000328	0.00454	CcSEcCtD
Flurandrenolide—Drospirenone—NR3C2—hypertension	0.000327	0.0546	CrCbGaD
Flurandrenolide—Infection—Propranolol—hypertension	0.000324	0.00449	CcSEcCtD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—hypertension	0.000323	0.0138	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Guanfacine—hypertension	0.000323	0.00447	CcSEcCtD
Flurandrenolide—Pruritus—Quinapril—hypertension	0.000323	0.00447	CcSEcCtD
Flurandrenolide—Hypersensitivity—Nicardipine—hypertension	0.000322	0.00446	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—hypertension	0.000319	0.0136	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Metolazone—hypertension	0.000318	0.00441	CcSEcCtD
Flurandrenolide—Hypersensitivity—Felodipine—hypertension	0.000318	0.00441	CcSEcCtD
Flurandrenolide—Pruritus—Benazepril—hypertension	0.000318	0.00439	CcSEcCtD
Flurandrenolide—Hypersensitivity—Spironolactone—hypertension	0.000317	0.00439	CcSEcCtD
Flurandrenolide—Rash—Bepridil—hypertension	0.000317	0.00439	CcSEcCtD
Flurandrenolide—Dermatitis—Bepridil—hypertension	0.000317	0.00438	CcSEcCtD
Flurandrenolide—Pruritus—Nadolol—hypertension	0.000316	0.00438	CcSEcCtD
Flurandrenolide—Infection—Diltiazem—hypertension	0.000314	0.00434	CcSEcCtD
Flurandrenolide—Infection—Indapamide—hypertension	0.000314	0.00434	CcSEcCtD
Flurandrenolide—Pruritus—Isradipine—hypertension	0.000312	0.00431	CcSEcCtD
Flurandrenolide—Infection—Carvedilol—hypertension	0.000311	0.0043	CcSEcCtD
Flurandrenolide—Pruritus—Guanfacine—hypertension	0.00031	0.00429	CcSEcCtD
Flurandrenolide—NR3C1—adrenal gland—hypertension	0.000309	0.0244	CbGeAlD
Flurandrenolide—Fludrocortisone—NR3C2—hypertension	0.000308	0.0514	CrCbGaD
Flurandrenolide—Infection—Doxazosin—hypertension	0.000307	0.00425	CcSEcCtD
Flurandrenolide—Hypersensitivity—Terazosin—hypertension	0.000307	0.00424	CcSEcCtD
Flurandrenolide—Rash—Candesartan—hypertension	0.000306	0.00424	CcSEcCtD
Flurandrenolide—Dermatitis—Candesartan—hypertension	0.000306	0.00423	CcSEcCtD
Flurandrenolide—Pruritus—Metolazone—hypertension	0.000306	0.00423	CcSEcCtD
Flurandrenolide—Pruritus—Felodipine—hypertension	0.000306	0.00423	CcSEcCtD
Flurandrenolide—Pruritus—Spironolactone—hypertension	0.000305	0.00422	CcSEcCtD
Flurandrenolide—Infection—Fosinopril—hypertension	0.000304	0.0042	CcSEcCtD
Flurandrenolide—Infection—Eplerenone—hypertension	0.000302	0.00418	CcSEcCtD
Flurandrenolide—Rash—Methyldopa—hypertension	0.000302	0.00418	CcSEcCtD
Flurandrenolide—Dermatitis—Methyldopa—hypertension	0.000302	0.00417	CcSEcCtD
Flurandrenolide—Pruritus—Esmolol—hypertension	0.000298	0.00413	CcSEcCtD
Flurandrenolide—Infection—Verapamil—hypertension	0.000298	0.00413	CcSEcCtD
Flurandrenolide—Rash—Amiloride—hypertension	0.000296	0.0041	CcSEcCtD
Flurandrenolide—Rash—Hydralazine—hypertension	0.000296	0.0041	CcSEcCtD
Flurandrenolide—Hypersensitivity—Labetalol—hypertension	0.000296	0.0041	CcSEcCtD
Flurandrenolide—Dermatitis—Amiloride—hypertension	0.000296	0.0041	CcSEcCtD
Flurandrenolide—Dermatitis—Hydralazine—hypertension	0.000296	0.0041	CcSEcCtD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—hypertension	0.000295	0.0126	CbGpPWpGaD
Flurandrenolide—Pruritus—Terazosin—hypertension	0.000295	0.00407	CcSEcCtD
Flurandrenolide—Rash—Pindolol—hypertension	0.000293	0.00405	CcSEcCtD
Flurandrenolide—Dermatitis—Pindolol—hypertension	0.000292	0.00404	CcSEcCtD
Flurandrenolide—Rash—Quinapril—hypertension	0.000288	0.00398	CcSEcCtD
Flurandrenolide—Dermatitis—Quinapril—hypertension	0.000287	0.00398	CcSEcCtD
Flurandrenolide—Pruritus—Acebutolol—hypertension	0.000287	0.00397	CcSEcCtD
Flurandrenolide—Hypersensitivity—Eprosartan—hypertension	0.000287	0.00397	CcSEcCtD
Flurandrenolide—Pruritus—Labetalol—hypertension	0.000285	0.00394	CcSEcCtD
Flurandrenolide—Rash—Benazepril—hypertension	0.000283	0.00392	CcSEcCtD
Flurandrenolide—Dermatitis—Benazepril—hypertension	0.000283	0.00391	CcSEcCtD
Flurandrenolide—Rash—Nadolol—hypertension	0.000282	0.0039	CcSEcCtD
Flurandrenolide—Dermatitis—Nadolol—hypertension	0.000282	0.0039	CcSEcCtD
Flurandrenolide—Hypersensitivity—Nisoldipine—hypertension	0.000279	0.00386	CcSEcCtD
Flurandrenolide—Hypersensitivity—Amlodipine—hypertension	0.000279	0.00386	CcSEcCtD
Flurandrenolide—Infection—Valsartan—hypertension	0.000278	0.00384	CcSEcCtD
Flurandrenolide—Rash—Isradipine—hypertension	0.000278	0.00384	CcSEcCtD
Flurandrenolide—Dermatitis—Isradipine—hypertension	0.000277	0.00384	CcSEcCtD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—hypertension	0.000277	0.0118	CbGpPWpGaD
Flurandrenolide—Rash—Guanfacine—hypertension	0.000277	0.00383	CcSEcCtD
Flurandrenolide—Infection—Olmesartan—hypertension	0.000276	0.00382	CcSEcCtD
Flurandrenolide—Dermatitis—Guanfacine—hypertension	0.000276	0.00382	CcSEcCtD
Flurandrenolide—Pruritus—Eprosartan—hypertension	0.000276	0.00381	CcSEcCtD
Flurandrenolide—Rash—Nicardipine—hypertension	0.000276	0.00381	CcSEcCtD
Flurandrenolide—Dermatitis—Nicardipine—hypertension	0.000275	0.00381	CcSEcCtD
Flurandrenolide—Rash—Metolazone—hypertension	0.000273	0.00377	CcSEcCtD
Flurandrenolide—Rash—Felodipine—hypertension	0.000273	0.00377	CcSEcCtD
Flurandrenolide—Dermatitis—Felodipine—hypertension	0.000272	0.00377	CcSEcCtD
Flurandrenolide—Dermatitis—Metolazone—hypertension	0.000272	0.00377	CcSEcCtD
Flurandrenolide—Rash—Spironolactone—hypertension	0.000272	0.00376	CcSEcCtD
Flurandrenolide—Dermatitis—Spironolactone—hypertension	0.000271	0.00375	CcSEcCtD
Flurandrenolide—NR3C1—endocrine gland—hypertension	0.000268	0.0212	CbGeAlD
Flurandrenolide—Pruritus—Amlodipine—hypertension	0.000268	0.0037	CcSEcCtD
Flurandrenolide—Pruritus—Nisoldipine—hypertension	0.000268	0.0037	CcSEcCtD
Flurandrenolide—Infection—Clonidine—hypertension	0.000265	0.00366	CcSEcCtD
Flurandrenolide—Rash—Terazosin—hypertension	0.000262	0.00363	CcSEcCtD
Flurandrenolide—Dermatitis—Terazosin—hypertension	0.000262	0.00363	CcSEcCtD
Flurandrenolide—Hypersensitivity—Guanabenz—hypertension	0.000262	0.00362	CcSEcCtD
Flurandrenolide—Hypersensitivity—Metoprolol—hypertension	0.000262	0.00362	CcSEcCtD
Flurandrenolide—Infection—Trandolapril—hypertension	0.000258	0.00357	CcSEcCtD
Flurandrenolide—Rash—Acebutolol—hypertension	0.000256	0.00354	CcSEcCtD
Flurandrenolide—Dermatitis—Acebutolol—hypertension	0.000256	0.00354	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—NFATC2—hypertension	0.000254	0.0108	CbGpPWpGaD
Flurandrenolide—Infection—Telmisartan—hypertension	0.000254	0.00351	CcSEcCtD
Flurandrenolide—Rash—Labetalol—hypertension	0.000254	0.00351	CcSEcCtD
Flurandrenolide—Dermatitis—Labetalol—hypertension	0.000253	0.0035	CcSEcCtD
Flurandrenolide—Pruritus—Guanabenz—hypertension	0.000252	0.00348	CcSEcCtD
Flurandrenolide—Pruritus—Metoprolol—hypertension	0.000252	0.00348	CcSEcCtD
Flurandrenolide—Rash—Eprosartan—hypertension	0.000246	0.0034	CcSEcCtD
Flurandrenolide—Dermatitis—Eprosartan—hypertension	0.000245	0.0034	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hypertension	0.000245	0.0104	CbGpPWpGaD
Flurandrenolide—NR3C1—central nervous system—hypertension	0.000242	0.0191	CbGeAlD
Flurandrenolide—Hypersensitivity—Propranolol—hypertension	0.000241	0.00333	CcSEcCtD
Flurandrenolide—Infection—Irbesartan—hypertension	0.000239	0.0033	CcSEcCtD
Flurandrenolide—Rash—Nisoldipine—hypertension	0.000238	0.0033	CcSEcCtD
Flurandrenolide—Rash—Amlodipine—hypertension	0.000238	0.0033	CcSEcCtD
Flurandrenolide—Dermatitis—Nisoldipine—hypertension	0.000238	0.0033	CcSEcCtD
Flurandrenolide—Dermatitis—Amlodipine—hypertension	0.000238	0.0033	CcSEcCtD
Flurandrenolide—Hypersensitivity—Diltiazem—hypertension	0.000233	0.00322	CcSEcCtD
Flurandrenolide—Hypersensitivity—Indapamide—hypertension	0.000233	0.00322	CcSEcCtD
Flurandrenolide—Hydrocortisone—CYP11B1—hypertension	0.000232	0.0387	CrCbGaD
Flurandrenolide—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—hypertension	0.000231	0.00983	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Carvedilol—hypertension	0.000231	0.00319	CcSEcCtD
Flurandrenolide—Infection—Betaxolol—hypertension	0.00023	0.00319	CcSEcCtD
Flurandrenolide—NR3C1—Endoderm Differentiation—GATA4—hypertension	0.00023	0.00979	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—ESR2—hypertension	0.000229	0.00975	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Doxazosin—hypertension	0.000228	0.00315	CcSEcCtD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—LEP—hypertension	0.000225	0.00959	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Fosinopril—hypertension	0.000225	0.00312	CcSEcCtD
Flurandrenolide—Infection—Losartan—hypertension	0.000225	0.00311	CcSEcCtD
Flurandrenolide—Rash—Metoprolol—hypertension	0.000224	0.0031	CcSEcCtD
Flurandrenolide—Rash—Guanabenz—hypertension	0.000224	0.0031	CcSEcCtD
Flurandrenolide—Dermatitis—Metoprolol—hypertension	0.000224	0.0031	CcSEcCtD
Flurandrenolide—Dermatitis—Guanabenz—hypertension	0.000224	0.0031	CcSEcCtD
Flurandrenolide—Pruritus—Indapamide—hypertension	0.000224	0.00309	CcSEcCtD
Flurandrenolide—Pruritus—Diltiazem—hypertension	0.000224	0.00309	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—RETN—hypertension	0.000223	0.00951	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Nifedipine—hypertension	0.000222	0.00307	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—DUSP1—hypertension	0.000222	0.00946	CbGpPWpGaD
Flurandrenolide—Pruritus—Carvedilol—hypertension	0.000221	0.00306	CcSEcCtD
Flurandrenolide—Hypersensitivity—Verapamil—hypertension	0.000221	0.00306	CcSEcCtD
Flurandrenolide—Pruritus—Doxazosin—hypertension	0.000219	0.00303	CcSEcCtD
Flurandrenolide—Hydrocortisone—CYP11B2—hypertension	0.000218	0.0364	CrCbGaD
Flurandrenolide—Pruritus—Fosinopril—hypertension	0.000216	0.00299	CcSEcCtD
Flurandrenolide—Pruritus—Eplerenone—hypertension	0.000215	0.00297	CcSEcCtD
Flurandrenolide—Pruritus—Nifedipine—hypertension	0.000213	0.00295	CcSEcCtD
Flurandrenolide—Pruritus—Verapamil—hypertension	0.000212	0.00294	CcSEcCtD
Flurandrenolide—Hypersensitivity—Valsartan—hypertension	0.000206	0.00285	CcSEcCtD
Flurandrenolide—Rash—Propranolol—hypertension	0.000206	0.00285	CcSEcCtD
Flurandrenolide—Dermatitis—Propranolol—hypertension	0.000206	0.00285	CcSEcCtD
Flurandrenolide—NR3C1—Nuclear Receptors—AR—hypertension	0.000202	0.00862	CbGpPWpGaD
Flurandrenolide—Prednisolone—NR3C2—hypertension	0.000202	0.0338	CrCbGaD
Flurandrenolide—NR3C1—Circadian Clock—F7—hypertension	0.000202	0.0086	CbGpPWpGaD
Flurandrenolide—Rash—Diltiazem—hypertension	0.000199	0.00276	CcSEcCtD
Flurandrenolide—Rash—Indapamide—hypertension	0.000199	0.00276	CcSEcCtD
Flurandrenolide—Dermatitis—Indapamide—hypertension	0.000199	0.00275	CcSEcCtD
Flurandrenolide—Dermatitis—Diltiazem—hypertension	0.000199	0.00275	CcSEcCtD
Flurandrenolide—Betamethasone—NR3C2—hypertension	0.000198	0.0331	CrCbGaD
Flurandrenolide—Pruritus—Valsartan—hypertension	0.000198	0.00274	CcSEcCtD
Flurandrenolide—Rash—Carvedilol—hypertension	0.000197	0.00273	CcSEcCtD
Flurandrenolide—Hydrocortisone—ANXA1—hypertension	0.000197	0.0329	CrCbGaD
Flurandrenolide—Dermatitis—Carvedilol—hypertension	0.000197	0.00273	CcSEcCtD
Flurandrenolide—Pruritus—Olmesartan—hypertension	0.000197	0.00272	CcSEcCtD
Flurandrenolide—Hypersensitivity—Clonidine—hypertension	0.000196	0.00272	CcSEcCtD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—hypertension	0.000196	0.00836	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—NPPA—hypertension	0.000196	0.00834	CbGpPWpGaD
Flurandrenolide—Rash—Doxazosin—hypertension	0.000195	0.0027	CcSEcCtD
Flurandrenolide—Dermatitis—Doxazosin—hypertension	0.000195	0.0027	CcSEcCtD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—hypertension	0.000195	0.00829	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—KCNJ8—hypertension	0.000193	0.00822	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—KCNQ1—hypertension	0.000193	0.00822	CbGpPWpGaD
Flurandrenolide—Rash—Fosinopril—hypertension	0.000193	0.00267	CcSEcCtD
Flurandrenolide—Dermatitis—Fosinopril—hypertension	0.000193	0.00266	CcSEcCtD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypertension	0.000192	0.00818	CbGpPWpGaD
Flurandrenolide—Rash—Eplerenone—hypertension	0.000192	0.00265	CcSEcCtD
Flurandrenolide—Hypersensitivity—Trandolapril—hypertension	0.000191	0.00265	CcSEcCtD
Flurandrenolide—Dermatitis—Eplerenone—hypertension	0.000191	0.00265	CcSEcCtD
Flurandrenolide—Hypersensitivity—Enalapril—hypertension	0.000191	0.00264	CcSEcCtD
Flurandrenolide—Rash—Nifedipine—hypertension	0.00019	0.00263	CcSEcCtD
Flurandrenolide—Dermatitis—Nifedipine—hypertension	0.00019	0.00263	CcSEcCtD
Flurandrenolide—Rash—Verapamil—hypertension	0.000189	0.00262	CcSEcCtD
Flurandrenolide—Dermatitis—Verapamil—hypertension	0.000189	0.00262	CcSEcCtD
Flurandrenolide—Pruritus—Clonidine—hypertension	0.000189	0.00261	CcSEcCtD
Flurandrenolide—Infection—Timolol—hypertension	0.000188	0.00261	CcSEcCtD
Flurandrenolide—Hypersensitivity—Telmisartan—hypertension	0.000188	0.0026	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—hypertension	0.000187	0.00798	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP4A11—hypertension	0.000186	0.031	CrCbGaD
Flurandrenolide—Pruritus—Trandolapril—hypertension	0.000184	0.00254	CcSEcCtD
Flurandrenolide—Pruritus—Enalapril—hypertension	0.000183	0.00253	CcSEcCtD
Flurandrenolide—NR3C1—Nuclear Receptors—VDR—hypertension	0.000182	0.00774	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—ESR2—hypertension	0.000181	0.00771	CbGpPWpGaD
Flurandrenolide—Pruritus—Telmisartan—hypertension	0.000181	0.0025	CcSEcCtD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—ECE1—hypertension	0.00018	0.00764	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Irbesartan—hypertension	0.000177	0.00245	CcSEcCtD
Flurandrenolide—Rash—Valsartan—hypertension	0.000176	0.00244	CcSEcCtD
Flurandrenolide—Dermatitis—Valsartan—hypertension	0.000176	0.00244	CcSEcCtD
Flurandrenolide—Pruritus—Captopril—hypertension	0.000176	0.00243	CcSEcCtD
Flurandrenolide—Hypersensitivity—Hydrochlorothiazide—hypertension	0.000176	0.00243	CcSEcCtD
Flurandrenolide—Rash—Olmesartan—hypertension	0.000175	0.00243	CcSEcCtD
Flurandrenolide—Dermatitis—Olmesartan—hypertension	0.000175	0.00242	CcSEcCtD
Flurandrenolide—Infection—Lisinopril—hypertension	0.000175	0.00242	CcSEcCtD
Flurandrenolide—Hypersensitivity—Furosemide—hypertension	0.000173	0.00239	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—SELE—hypertension	0.000173	0.00735	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Betaxolol—hypertension	0.000171	0.00237	CcSEcCtD
Flurandrenolide—Pruritus—Perindopril—hypertension	0.000171	0.00236	CcSEcCtD
Flurandrenolide—Pruritus—Irbesartan—hypertension	0.00017	0.00235	CcSEcCtD
Flurandrenolide—Pruritus—Hydrochlorothiazide—hypertension	0.000169	0.00233	CcSEcCtD
Flurandrenolide—Rash—Clonidine—hypertension	0.000168	0.00232	CcSEcCtD
Flurandrenolide—Dermatitis—Clonidine—hypertension	0.000168	0.00232	CcSEcCtD
Flurandrenolide—Hypersensitivity—Losartan—hypertension	0.000167	0.0023	CcSEcCtD
Flurandrenolide—Pruritus—Furosemide—hypertension	0.000166	0.00229	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—EGR1—hypertension	0.000164	0.00699	CbGpPWpGaD
Flurandrenolide—Pruritus—Betaxolol—hypertension	0.000164	0.00227	CcSEcCtD
Flurandrenolide—Rash—Trandolapril—hypertension	0.000164	0.00227	CcSEcCtD
Flurandrenolide—Dermatitis—Trandolapril—hypertension	0.000164	0.00227	CcSEcCtD
Flurandrenolide—Rash—Enalapril—hypertension	0.000163	0.00226	CcSEcCtD
Flurandrenolide—Dermatitis—Enalapril—hypertension	0.000163	0.00226	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—MIF—hypertension	0.000163	0.00694	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—PTGIS—hypertension	0.000163	0.00694	CbGpPWpGaD
Flurandrenolide—Rash—Telmisartan—hypertension	0.000161	0.00223	CcSEcCtD
Flurandrenolide—Dermatitis—Telmisartan—hypertension	0.000161	0.00223	CcSEcCtD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—SLC9A3—hypertension	0.00016	0.00681	CbGpPWpGaD
Flurandrenolide—Pruritus—Losartan—hypertension	0.00016	0.00221	CcSEcCtD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—AR—hypertension	0.00016	0.00681	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—HDAC1—hypertension	0.000159	0.00679	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—hypertension	0.000157	0.00667	CbGpPWpGaD
Flurandrenolide—Rash—Captopril—hypertension	0.000157	0.00217	CcSEcCtD
Flurandrenolide—Dermatitis—Captopril—hypertension	0.000156	0.00216	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—AR—hypertension	0.000155	0.0066	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—PPARA—hypertension	0.000153	0.00653	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—IL13—hypertension	0.000153	0.00651	CbGpPWpGaD
Flurandrenolide—Clocortolone—NR3C1—hypertension	0.000152	0.0254	CrCbGaD
Flurandrenolide—Rash—Perindopril—hypertension	0.000152	0.0021	CcSEcCtD
Flurandrenolide—Dermatitis—Perindopril—hypertension	0.000152	0.0021	CcSEcCtD
Flurandrenolide—Rash—Irbesartan—hypertension	0.000151	0.0021	CcSEcCtD
Flurandrenolide—Dermatitis—Irbesartan—hypertension	0.000151	0.00209	CcSEcCtD
Flurandrenolide—Rash—Hydrochlorothiazide—hypertension	0.00015	0.00208	CcSEcCtD
Flurandrenolide—Dermatitis—Hydrochlorothiazide—hypertension	0.00015	0.00208	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TIMP1—hypertension	0.000148	0.00632	CbGpPWpGaD
Flurandrenolide—Rash—Furosemide—hypertension	0.000148	0.00204	CcSEcCtD
Flurandrenolide—Dermatitis—Furosemide—hypertension	0.000148	0.00204	CcSEcCtD
Flurandrenolide—Dexamethasone—ANXA1—hypertension	0.000147	0.0245	CrCbGaD
Flurandrenolide—Rash—Betaxolol—hypertension	0.000146	0.00202	CcSEcCtD
Flurandrenolide—Dermatitis—Betaxolol—hypertension	0.000146	0.00202	CcSEcCtD
Flurandrenolide—Drospirenone—AR—hypertension	0.000146	0.0243	CrCbGaD
Flurandrenolide—Desonide—NR3C1—hypertension	0.000144	0.0241	CrCbGaD
Flurandrenolide—Diflorasone—NR3C1—hypertension	0.000144	0.0241	CrCbGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—VDR—hypertension	0.000144	0.00612	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Ramipril—hypertension	0.000143	0.00198	CcSEcCtD
Flurandrenolide—Rash—Losartan—hypertension	0.000143	0.00197	CcSEcCtD
Flurandrenolide—Dermatitis—Losartan—hypertension	0.000142	0.00197	CcSEcCtD
Flurandrenolide—NR3C1—Circadian Clock—PPARGC1A—hypertension	0.000142	0.00604	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—AVP—hypertension	0.00014	0.00596	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Timolol—hypertension	0.00014	0.00193	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TH—hypertension	0.00014	0.00594	CbGpPWpGaD
Flurandrenolide—Pruritus—Ramipril—hypertension	0.000137	0.0019	CcSEcCtD
Flurandrenolide—Fludrocortisone—AR—hypertension	0.000137	0.0229	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—GATA4—hypertension	0.000137	0.00583	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—TPH1—hypertension	0.000136	0.00579	CbGpPWpGaD
Flurandrenolide—Pruritus—Timolol—hypertension	0.000134	0.00186	CcSEcCtD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hypertension	0.000132	0.00561	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—EGR1—hypertension	0.000131	0.0056	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Lisinopril—hypertension	0.00013	0.00179	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—hypertension	0.000128	0.00545	CbGpPWpGaD
Flurandrenolide—Medrysone—NR3C1—hypertension	0.000128	0.0213	CrCbGaD
Flurandrenolide—NR3C1—Nuclear Receptors—PPARG—hypertension	0.000127	0.0054	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—GJA1—hypertension	0.000125	0.00533	CbGpPWpGaD
Flurandrenolide—Pruritus—Lisinopril—hypertension	0.000124	0.00172	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—AHR—hypertension	0.000122	0.00521	CbGpPWpGaD
Flurandrenolide—Rash—Ramipril—hypertension	0.000122	0.00169	CcSEcCtD
Flurandrenolide—Dermatitis—Ramipril—hypertension	0.000122	0.00169	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—hypertension	0.000122	0.0052	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—PPARA—hypertension	0.000121	0.00516	CbGpPWpGaD
Flurandrenolide—Rash—Timolol—hypertension	0.00012	0.00165	CcSEcCtD
Flurandrenolide—Dermatitis—Timolol—hypertension	0.000119	0.00165	CcSEcCtD
Flurandrenolide—Hydrocortamate—NR3C1—hypertension	0.000119	0.0199	CrCbGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HADHA—hypertension	0.000118	0.00504	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—hypertension	0.000117	0.00497	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—hypertension	0.000116	0.00493	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—AQP4—hypertension	0.000116	0.00493	CbGpPWpGaD
Flurandrenolide—Dexamethasone—NR3C2—hypertension	0.000115	0.0192	CrCbGaD
Flurandrenolide—NR3C1—Circadian Clock—PPARA—hypertension	0.000114	0.00486	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypertension	0.000114	0.00486	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—hypertension	0.000114	0.00483	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—hypertension	0.000112	0.00479	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—HIF1A—hypertension	0.000111	0.00472	CbGpPWpGaD
Flurandrenolide—Rash—Lisinopril—hypertension	0.000111	0.00153	CcSEcCtD
Flurandrenolide—Amcinonide—NR3C1—hypertension	0.000111	0.0185	CrCbGaD
Flurandrenolide—Budesonide—NR3C1—hypertension	0.000111	0.0185	CrCbGaD
Flurandrenolide—Dermatitis—Lisinopril—hypertension	0.000111	0.00153	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—hypertension	0.000111	0.00471	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hypertension	0.00011	0.0047	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—EDN1—hypertension	0.00011	0.00467	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HSPD1—hypertension	0.000109	0.00463	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—IL10—hypertension	0.000109	0.00462	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—hypertension	0.000104	0.00444	CbGpPWpGaD
Flurandrenolide—Rimexolone—NR3C1—hypertension	0.000104	0.0174	CrCbGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—TACR1—hypertension	0.000103	0.00439	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hypertension	0.000101	0.00432	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—PPARG—hypertension	0.0001	0.00426	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—hypertension	9.93e-05	0.00423	CbGpPWpGaD
Flurandrenolide—Fluocinonide—NR3C1—hypertension	9.82e-05	0.0164	CrCbGaD
Flurandrenolide—Medroxyprogesterone Acetate—AR—hypertension	9.71e-05	0.0162	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hypertension	9.66e-05	0.00411	CbGpPWpGaD
Flurandrenolide—Fluocinolone Acetonide—NR3C1—hypertension	9.55e-05	0.0159	CrCbGaD
Flurandrenolide—Alclometasone—NR3C1—hypertension	9.55e-05	0.0159	CrCbGaD
Flurandrenolide—Fludrocortisone—NR3C1—hypertension	9.3e-05	0.0155	CrCbGaD
Flurandrenolide—Flunisolide—NR3C1—hypertension	9.3e-05	0.0155	CrCbGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MMP1—hypertension	9.23e-05	0.00393	CbGpPWpGaD
Flurandrenolide—Paramethasone—NR3C1—hypertension	9.18e-05	0.0153	CrCbGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—HIF1A—hypertension	9.15e-05	0.00389	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL13—hypertension	9.14e-05	0.00389	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—AGT—hypertension	9.11e-05	0.00388	CbGpPWpGaD
Flurandrenolide—Ciclesonide—NR3C1—hypertension	9.03e-05	0.0151	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—ADIPOQ—hypertension	8.76e-05	0.00373	CbGpPWpGaD
Flurandrenolide—Methylprednisolone—NR3C1—hypertension	8.66e-05	0.0144	CrCbGaD
Flurandrenolide—NR3C1—Circadian Clock—SERPINE1—hypertension	8.5e-05	0.00362	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hypertension	8.47e-05	0.00361	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP17A1—hypertension	8.44e-05	0.0141	CrCbGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—NOTCH1—hypertension	8.43e-05	0.00359	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—hypertension	8.41e-05	0.00358	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—TAC1—hypertension	8.41e-05	0.00358	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP11A1—hypertension	8.3e-05	0.0139	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—SLC2A4—hypertension	8.27e-05	0.00352	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—hypertension	8.25e-05	0.00351	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—hypertension	8.13e-05	0.00346	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—SST—hypertension	8.02e-05	0.00341	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL1RN—hypertension	7.99e-05	0.0034	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—FOS—hypertension	7.68e-05	0.00327	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CCL2—hypertension	7.5e-05	0.00319	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—ESR2—hypertension	7.4e-05	0.00315	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hypertension	7.39e-05	0.00315	CbGpPWpGaD
Flurandrenolide—Betamethasone—CYP19A1—hypertension	7.38e-05	0.0123	CrCbGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—TH—hypertension	7.35e-05	0.00313	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—PPARGC1A—hypertension	7.13e-05	0.00304	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NR3C2—hypertension	6.94e-05	0.00295	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—EGR1—hypertension	6.92e-05	0.00295	CbGpPWpGaD
Flurandrenolide—Dexamethasone—NOS2—hypertension	6.88e-05	0.0115	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hypertension	6.84e-05	0.00291	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—FOS—hypertension	6.77e-05	0.00288	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypertension	6.76e-05	0.00288	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HDAC1—hypertension	6.72e-05	0.00286	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—GJA1—hypertension	6.59e-05	0.00281	CbGpPWpGaD
Flurandrenolide—Medroxyprogesterone Acetate—NR3C1—hypertension	6.59e-05	0.011	CrCbGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CDKN2A—hypertension	6.54e-05	0.00279	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—AR—hypertension	6.54e-05	0.00278	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—MAPK8—hypertension	6.52e-05	0.00278	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—LPL—hypertension	6.49e-05	0.00276	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—EP300—hypertension	6.36e-05	0.00271	CbGpPWpGaD
Flurandrenolide—Hydrocortisone—CYP3A5—hypertension	6.25e-05	0.0104	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—hypertension	6.23e-05	0.00265	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—SRC—hypertension	6.18e-05	0.00263	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—EP300—hypertension	6.17e-05	0.00263	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—GNB3—hypertension	6.16e-05	0.00262	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—hypertension	6.16e-05	0.00262	CbGpPWpGaD
Flurandrenolide—Prednisolone—NR3C1—hypertension	6.11e-05	0.0102	CrCbGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—AVP—hypertension	6.08e-05	0.00259	CbGpPWpGaD
Flurandrenolide—Betamethasone—NR3C1—hypertension	5.98e-05	0.00998	CrCbGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CXCL8—hypertension	5.93e-05	0.00253	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NEDD4L—hypertension	5.75e-05	0.00245	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—PPARA—hypertension	5.73e-05	0.00244	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL10—hypertension	5.72e-05	0.00243	CbGpPWpGaD
Flurandrenolide—Drospirenone—PTGS2—hypertension	5.6e-05	0.00935	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—HIF1A—hypertension	5.57e-05	0.00237	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—AGT—hypertension	5.55e-05	0.00236	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—RELA—hypertension	5.55e-05	0.00236	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—LEP—hypertension	5.44e-05	0.00232	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—hypertension	5.37e-05	0.00229	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MMP9—hypertension	5.37e-05	0.00228	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—PTEN—hypertension	5.33e-05	0.00227	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—NGF—hypertension	5.31e-05	0.00226	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—hypertension	5.23e-05	0.00223	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—EP300—hypertension	5.09e-05	0.00217	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HTR2A—hypertension	5.06e-05	0.00215	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—GATA4—hypertension	5e-05	0.00213	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—hypertension	4.82e-05	0.00205	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hypertension	4.76e-05	0.00203	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—PPARG—hypertension	4.74e-05	0.00202	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hypertension	4.71e-05	0.00201	CbGpPWpGaD
Flurandrenolide—Hydrocortisone—NR3C1—hypertension	4.67e-05	0.00779	CrCbGaD
Flurandrenolide—Dexamethasone—CYP3A5—hypertension	4.66e-05	0.00777	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—INS—hypertension	4.65e-05	0.00198	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hypertension	4.6e-05	0.00196	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hypertension	4.53e-05	0.00193	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—TGFB1—hypertension	4.53e-05	0.00193	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—IGF1—hypertension	4.5e-05	0.00191	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—EP300—hypertension	4.48e-05	0.00191	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hypertension	4.46e-05	0.0019	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MYC—hypertension	4.43e-05	0.00189	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TGFB1—hypertension	4.42e-05	0.00188	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NPPA—hypertension	4.36e-05	0.00186	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP19A1—hypertension	4.29e-05	0.00716	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—SERPINE1—hypertension	4.27e-05	0.00182	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hypertension	3.94e-05	0.00168	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TP53—hypertension	3.64e-05	0.00155	CbGpPWpGaD
Flurandrenolide—Dexamethasone—NR3C1—hypertension	3.48e-05	0.0058	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—CTGF—hypertension	3.42e-05	0.00146	CbGpPWpGaD
Flurandrenolide—Betamethasone—PTGS2—hypertension	3.39e-05	0.00566	CrCbGaD
Flurandrenolide—NR3C1—Gene Expression—NR3C2—hypertension	3.34e-05	0.00142	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—IL6—hypertension	3.33e-05	0.00142	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—CDKN1A—hypertension	3.26e-05	0.00139	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—hypertension	3.21e-05	0.00137	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP1A1—hypertension	3.16e-05	0.00527	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—ESR2—hypertension	3.13e-05	0.00133	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—hypertension	3.12e-05	0.00133	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL1B—hypertension	3e-05	0.00128	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NOTCH2—hypertension	2.96e-05	0.00126	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—hypertension	2.94e-05	0.00125	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—HDAC1—hypertension	2.84e-05	0.00121	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NEDD4L—hypertension	2.77e-05	0.00118	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—AR—hypertension	2.76e-05	0.00118	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hypertension	2.74e-05	0.00116	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hypertension	2.71e-05	0.00115	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—TGFB1—hypertension	2.7e-05	0.00115	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—EP300—hypertension	2.68e-05	0.00114	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hypertension	2.54e-05	0.00108	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—TNF—hypertension	2.52e-05	0.00107	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—VDR—hypertension	2.48e-05	0.00106	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—GATA4—hypertension	2.41e-05	0.00103	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—TNF—hypertension	2.18e-05	0.000926	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NPPA—hypertension	2.1e-05	0.000893	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—PPARA—hypertension	2.09e-05	0.000891	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—IL6—hypertension	2.03e-05	0.000865	CbGpPWpGaD
Flurandrenolide—Dexamethasone—PTGS2—hypertension	1.97e-05	0.00329	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NOTCH1—hypertension	1.83e-05	0.000781	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL6—hypertension	1.76e-05	0.000747	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—PPARG—hypertension	1.73e-05	0.000737	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—CTGF—hypertension	1.65e-05	0.000701	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—SERPINE1—hypertension	1.56e-05	0.000664	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—ESR2—hypertension	1.51e-05	0.000641	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NOTCH2—hypertension	1.43e-05	0.000607	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HDAC1—hypertension	1.37e-05	0.000582	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—AR—hypertension	1.33e-05	0.000566	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—VDR—hypertension	1.2e-05	0.000509	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—H2AFX—hypertension	1.13e-05	0.000482	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PRKCA—hypertension	1.1e-05	0.000469	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—YWHAZ—hypertension	1.09e-05	0.000465	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PRKCD—hypertension	1.05e-05	0.000448	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PPARA—hypertension	1.01e-05	0.000429	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—MYC—hypertension	9.87e-06	0.00042	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NOTCH1—hypertension	8.83e-06	0.000376	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PPARG—hypertension	8.33e-06	0.000355	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—SERPINE1—hypertension	7.51e-06	0.00032	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—MYC—hypertension	4.75e-06	0.000202	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—AKT1—hypertension	3.29e-06	0.00014	CbGpPWpGaD
